Repetitive transcranial magnetic stimulation (rTMS) ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 13 | Multiple sclerosis/Neuromyelitis optica | 1 |
13. Multiple sclerosis/Neuromyelitis optica
Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03723434 (ClinicalTrials.gov) | May 31, 2017 | 22/10/2018 | Physiology of Interregional Connectivity in the Human Brain | Physiology of Interregional Connectivity in the Human Brain | Healthy;Stroke;Traumatic Brain Injury;Multiple Sclerosis | Device: Single-pulse transcranial magnetic stimulation (spTMS);Device: Paired associative stimulation (PAS);Device: Repetitive transcranial magnetic stimulation (rTMS) | Shirley Ryan AbilityLab | Northwestern University | Unknown status | 18 Years | 85 Years | All | 76 | N/A | United States |